CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company
4D Molecular Therapeutics, Inc.
Sign in to watch- Ticker
- FDMT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473506994
- Phone
- 5105052680
- Business address
- 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
- 4 Open-market buy 10% owner bought 850,000 shares at $16.00 ($13,600,000)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 424B5 Offering Prospectus
- 4 Gift Chief Executive Officer gave 600,000 shares (gift)
- 424B5 Offering Prospectus
- S-8 POS Other Post-effective Amendment
- 4 Planned sale Chief Legal and HR Officer sold 3,750 shares at $20.00 ($75,000)
- 4 Planned sale Director sold 5,000 shares at $20.05 ($100,270)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 3 Insider Initial Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
- 10-K Report Annual Report
- 4 Open-market sale Chief Legal and HR Officer sold 2,248 shares at $19.30 ($43,386)
- 4 Open-market sale Chief Executive Officer sold 34,446 shares at an average $20.61 ($709,873)
Page 14 of 23 · 442 filings